Study Stopped
new law making inclusion impossible
Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE
ACCOMPAGNE
Evaluation of a Psycho-educational Program Based on the Prevention of the Risks Related to the Impact of Cognitive Disorders on Driving in Geriatrics and Neurology
1 other identifier
interventional
10
1 country
1
Brief Summary
ACCOMPAGNE study proposes to evaluate an educational program for the patient / caregiver dyad, intended to accompany the patient towards the implementation of self-regulation strategies in the driving activity. The program, based on group workshops with the presence of the patient and the caregiver, is led by an interdisciplinary team. It follows all the intervention recommendations described in the literature: to make the patient a decision-maker, to allow advanced planning of discussions between the family member and the caregiver, to give information on the consequences of TNCs and sensory disorders. This program provides psychological support in the management of the problems and the mourning of a future cessation of the driving activity, an awareness of the risky and avoidable situations, information on alternative solutions and available resources in the event of reduced driving. The program is created to support the implementation of self-regulation strategies for safe driving and a gradual reduction of driving activity. This study may be included in Measure 5 of the Neuro-Degenerative Diseases Plan (PMND) 2014-2019. This plan recommends to strengthen the self-management of patients and their relatives in the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2020
CompletedFirst Posted
Study publicly available on registry
July 30, 2020
CompletedStudy Start
First participant enrolled
September 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2022
CompletedMay 17, 2023
May 1, 2023
1.2 years
July 28, 2020
May 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
short term setting up self-regulation strategies
The score on the Driver Perception and Practices Questionnaires : DPPQ's "Current Self Regulatory Practices" subscale completed by the patient will be the primary outcome. The scores will be compared at 2 months between the control group and the experimental group. The Current Self Regulatory Practices subscale consists of 8 questions about how often participants set up self-regulation strategies (wait for the rain to stop before driving, ask someone to travel with them rather than drive alone, look for parking to avoid niches, avoid turning left in traffic, avoid taking the freeway, avoid driving at rush hour, avoid driving in crowded places, avoid driving the night). A four-point scale (0: never, 1: rarely, 2: sometimes, 3: often) collects the frequency. The score is calculated by summing the response values on the eight driving situations creating a total score ranging from 0 (never execute any of these strategies) to 24 (often performs all strategies).
at 2 months
Secondary Outcomes (11)
long term setting up self-regulation strategies
six months
Indicators of driving changes
two months and six months
Indicators of changes perceived by the caregiver
two months and six months
Indicators of awareness of driving difficulties
two months and six months
Indicators of Mood Effects of Conduct Modifications on the patient
two months and six months
- +6 more secondary outcomes
Study Arms (2)
educational intervention
EXPERIMENTALPatients and caregivers included in the "ACCOMPAGNE Education Program" group will benefit from seven group workshops spread over three half-days (once a week over 3 consecutive weeks), animated in pairs, each lasting approximately one and a half hours. and using educational pedagogical methods.
Control group
ACTIVE COMPARATORPatients and caregivers included in the "Control" group will receive the usual recommendations for driving, issued by their referring doctor in memory consultation during the diagnostic announcement process or during the follow-up of their illness.
Interventions
The following workshops will be organised : * Presentation workshop * Cognitive skills" workshop * Perception and Environment workshop * Responsibilities workshop * Representation workshop - * Caregivers workshop, * Solutions workshop
Recommendations consist of a description of the cognitive and sensorimotor risk factors specific to the patient for driving and advice for the adaptation of driving or the recommendation of the stopping of driving. It is usually served by oral or written to the patient, with mention in the patient's file of the recommendation and issued in the presence of his close companion.
Eligibility Criteria
You may qualify if:
- aged between 50 and 95 years-old
- hold a driving license,
- drive at least twice a week,
- to have given free and informed consent,
- present a diagnosis of major or minor CNS according to DSM V, whose clinically probable or definite etiology is Alzheimer's or related or vascular disease,
- have a result in the Mini Mental State Examination (MMSE) greater than 18,
- have the ability to speak orally enough or write enough to perform clinical evaluations and workshops, be accompanied by a family member present at least 4 hours a week.
- to be a caregiver helping the patient for activities of daily living,
- to have given their free and informed consent,
- have the ability to speak orally and write enough to perform clinical assessments.
You may not qualify if:
- have a major psychiatric history, history of alcoholism, anti-depressant
- have sensory problems preventing participation in workshops,
- be affected by any debilitating pathology compromising the health of the patient in the short and medium term,
- Recruited patients and caregivers should have been informed and signed a consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charpennes Hospital
Villeurbanne, 69100, France
Related Publications (1)
Delphin-Combe F, Coste MH, Bachelet R, Llorens M, Gentil C, Giroux M, Paire-Ficout L, Ranchet M, Krolak-Salmon P. An innovative therapeutic educational program to support older drivers with cognitive disorders: Description of a randomized controlled trial study protocol. Front Neurol. 2022 Jul 18;13:901100. doi: 10.3389/fneur.2022.901100. eCollection 2022.
PMID: 35923824DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single Blind
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2020
First Posted
July 30, 2020
Study Start
September 6, 2021
Primary Completion
November 15, 2022
Study Completion
November 15, 2022
Last Updated
May 17, 2023
Record last verified: 2023-05